Medline vs Stryker Corporation
Medline (MDLN) and Stryker Corporation (SYK) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $48.7B
- Last close
- $37.04
- 12 months
- —
- Market value
- $118B
- Last close
- $310.00
- 12 months
- −14.0%
At a glance
- The biggest part of Medline's revenue is Supply Chain Solutions (52%); at Stryker Corporation it is MedSurg and Neurotechnology (62%).
- Medline earns 93% of its revenue in the United States, Stryker Corporation 76%.
- By market value, Stryker Corporation ($118.0B) is about 2.4 times Medline ($48.7B).
- In their last fiscal years Medline kept 4.1% of revenue as net income and Stryker Corporation 12.9%.
- In the last 90 days insiders reported 0 open-market purchases at Medline and 1 at Stryker Corporation; members of Congress disclosed 0 trades in Medline and 2 in Stryker Corporation.
- Next results: Medline Feb 23, 2027, Stryker Corporation Jan 27, 2027.
How each one makes money: Medline revenue · Stryker Corporation revenue
Share prices on one chart
Medline and Stryker Corporation, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Medline MDLNNASDAQ · Surgical & Medical Instruments & Apparatus | Stryker Corporation SYKNYSE · Health Care Equipment | |
|---|---|---|
| Size and profitability | ||
| Market value | $48.7B | $118B |
| Revenue, last fiscal year | $28.4B | $25.1B |
| Net income, last fiscal year | $1.16B | $3.25B |
| Net marginNet income as a share of revenue | 4.1% | 12.9% |
| Free cash flow | $1.3B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Stryker Corporation against
Common questions
How is Medline different from Stryker Corporation?
Medline (MDLN) is in Surgical & Medical Instruments & Apparatus on NASDAQ, with $28.4B of revenue in its last fiscal year and a net margin of 4.1%. Stryker Corporation (SYK) is in Health Care Equipment on NYSE, with $25.1B of revenue in its last fiscal year and a net margin of 12.9%. The biggest part of Medline's revenue is Supply Chain Solutions (52%); at Stryker Corporation it is MedSurg and Neurotechnology (62%). Medline earns 93% of its revenue in the United States, Stryker Corporation 76%. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Medline and Stryker Corporation compare in size?
Stryker Corporation has the larger market value: Medline $48.7B and Stryker Corporation $118B, at the last close.
Whose share price rose more over the last 12 months, MDLN or SYK?
A 12-month price change is not available for both companies.
Which has had more insider buying, Medline or Stryker Corporation?
Since 2006, Stryker Corporation insiders reported 40 open-market purchases against 0 for Medline. These are counts of what was filed, not a view on either stock.
Do members of Congress trade MDLN or SYK?
In the last 12 months, members of Congress disclosed 0 trades in Medline (MDLN) and 11 in Stryker Corporation (SYK).
When did insiders last buy MDLN and SYK?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Medline pageStryker Corporation pageRare insider trades this weekAll comparisons
https://oqro.io/compare/mdln-vs-syk







